It will be easier for people with blood cancer and other serious conditions to get healthcare coverage under the Patient Protection and Affordable Care Act (ACA). However, the ACA permits variation among exchange plans, which could mean significant differences in services to people with blood cancer. This report provides an early look at the 2014 individual benefit designs and premiums for policies sold on state exchanges in California, New York, Florida, and Texas. This report reviews which drugs, cancer centers, and transplant centers are covered and discusses the role of out-of-pocket limits, as blood cancer treatment can be expensive and out-of-pocket limits will not apply to non-covered treatments and treatment centers.
Commissioned by the The Leukemia & Lymphoma Society